Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Seif el-Din S.H.; Salem M.B.; El-Lakkany N.M.; Hammam O.A.; Nasr S.M.; Okasha H.; Ahmed L.A.; Saleh S.; Botros S.S.

Journal: Human and Experimental Toxicology

Publisher: SAGE Publications Ltd

Publication Date: 8 March 2021

Volume / Issue: Volume 40 / Issue 9

Pages: 1496–1509

ISSN: 9603271

DOI: 10.1177/0960327121999445

Scopus: View on Scopus

PubMed: 33678036

Document Type: Article


Authors and Affiliations

Seif el-Din S.H., Pharmacology Department, Theodor Bilharz Research Institute, Warak El-Hadar, Imbaba, Giza, Egypt; Salem M.B., Pharmacology Department, Theodor Bilharz Research Institute, Warak El-Hadar, Imbaba, Giza, Egypt; El-Lakkany N.M., Pharmacology Department, Theodor Bilharz Research Institute, Warak El-Hadar, Imbaba, Giza, Egypt; Hammam O.A., Pathology Department, Theodor Bilharz Research Institute, Warak El-Hadar, Imbaba, Giza, Egypt; Nasr S.M., Biochemistry Department, Theodor Bilharz Research Institute, Warak El-Hadar, Imbaba, Giza, Egypt; Okasha H., Biochemistry Department, Theodor Bilharz Research Institute, Warak El-Hadar, Imbaba, Giza, Egypt; Ahmed L.A., Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt; Saleh S., Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt; Botros S.S., Pharmacology Department, Theodor Bilharz Research Institute, Warak El-Hadar, Imbaba, Giza, Egypt


Abstract

Non-alcoholic fatty liver disease (NAFLD) constitutes a major health problem worldwide and intimately links with obesity and diabetes. This study aimed to explore the therapeutic impact of early treatment with metformin (MTF) alone or in combination with Lactobacillus reuteri DSM 17938 (L. reuteri) + metronidazole (MTZ) in male Sprague Dawley rats with high-fat diet (HFD)-induced NAFLD. Hepatic steatosis was induced by feeding rats HFD for 6 weeks. MTF (150 mg/kg/day) or L. reuteri (2 × 109 colony forming unit/day) were given orally for 4 weeks; meanwhile, MTZ (15 mg/kg/day, p.o.) was administered for 1 week. Administration of L. reuteri + MTZ in combination with MTF produced a superior effect concerning insulin resistance (IR), lipid profile, liver function, oxidative stress, inflammatory and autophagic markers than using each treatment alone. Besides, this combination resulted in disappearance of steatosis, inflammation and vacuolation within hepatic architecture. Moreover, it normalized short chain fatty acids (SCFAs) as well as Firmicutes and Bacteroidetes faecal contents. In conclusion, early treatment with L. reuteri + MTZ in combination with MTF could prevent NAFLD progression and liver injury through targeting gut dysbiosis, inflammation and autophagic pathways. © The Author(s) 2021.


Keywords

Autophagy; dysbiosis; inflammation; Lactobacillus reuteri; NAFLD; Animals; Disease Models, Animal; Drug Therapy, Combination; Gastrointestinal Microbiome; Humans; Hypoglycemic Agents; Male; Metformin; Metronidazole; Non-alcoholic Fatty Liver Disease; Probiotics; Rats; Rats, Sprague-Dawley; lipid; mammalian target of rapamycin; probiotic agent; protein kinase B; short chain fatty acid; antidiabetic agent; animal experiment; animal model; animal tissue; Article; autophagy (cellular); Bacteroidetes; clinical effectiveness; colony forming unit; controlled study; dose response; drug effect; drug efficacy; drug mechanism; early intervention; fatty liver; feces analysis; Firmicutes; immunohistochemistry; insulin resistance; intestine flora; lipid blood level; lipid diet; liver function; liver injury; nonalcoholic fatty liver; nonhuman; oxidative stress; rat; signal transduction; Sprague Dawley rat; treatment outcome; animal; chemistry; combination drug therapy; disease model; human


Citation Information

Scopus Citations: 29


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]